Soft-Sensor Bioprocessing Patents: Top Companies & Trends 2026
Soft-Sensor Bioprocessing Inferential Estimation Patents
Concentrated at the top. The five most active filers hold 61.7% of all 60 records in scope, and the ten most active hold 88.3% — a long tail of single- or double-filing entrants fills the rest. Filings rose from 2 in 2017 to a peak of 11 in 2018, then eased through the early 2020s; the drop from 9 records in 2021 to 1 in 2024 (-89%) is the clearest complete-year signal in the set, since 2025 and 2026 are still being filled in by the publication lag.
- 1SARTORIUS STEDIM DATA ANALYTICS AB11
- 2GENERAL ELECTRIC CO7
- 3HONEYWELL INTERNATIONAL INC7
- 4FISHER ROSEMOUNT SYST INC7
- 5SIEMENS AG5
See the full soft-sensor bioprocessing inferential estimation analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Common questions on this landscape
What counts as a soft sensor in bioprocessing patents?
A soft sensor, also called a virtual or inferential sensor, is a model-based estimate of a process variable — biomass concentration, a metabolite level, or a product titre — that substitutes for or supplements a physical measurement that is slow, expensive, or unavailable in real time. In the patent literature this shows up as claims combining a state-estimation or uncertainty-modelling method with a control or AI classification. This dataset’s search string specifically pulls records that pair soft-sensor language with state-estimation, biomass-estimate, or prediction-interval terms, which is why the results lean toward control-engineering assignees rather than bioreactor hardware makers alone.
Who are the leading patent filers in soft-sensor bioprocessing estimation?
The ranked field covers 35 assignees, with one filer well ahead of the rest at 11 records against 5 at fifth place and 3 at tenth. The five most active filers together account for 61.7% of all 60 records in scope, and the ten most active for 88.3%, which makes this a concentrated field with a long tail of smaller and individual filers behind the leaders. Recent-year momentum data, however, shows even the largest corporate filers with zero records in the latest tracked year, a pattern that likely reflects publication lag as much as any genuine pull-back.
Is patent filing in this field growing or shrinking?
The only reliable year-over-year comparison in the data is 2021 to 2024, where filings fell 89% from 9 records to 1. Filing peaked earlier, in 2018, at 11 records. Counts for 2025 and 2026 are still filling in because publication typically lags actual filing by around eighteen months, so those recent years should be read as incomplete rather than as evidence the field has gone quiet.
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Soft-Sensor Bioprocessing Inferential Estimation covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.